ReAlta Life Sciences Expands Phase 1 Clinical Trial of RLS-0071 to Include Three Multiple-Ascending Dose Cohorts and An Additional Single Ascending Dose Cohort
In: Legal Monitor Worldwide, 2021-05-19
Zeitungsartikel
Zugriff:
ReAlta Life Sciences (ReAlta), Inc., a company addressing life-threatening diseases through harnessing the power of the immune system, today announced that it has received a no objection letter (NOL) from [...]
Titel: |
ReAlta Life Sciences Expands Phase 1 Clinical Trial of RLS-0071 to Include Three Multiple-Ascending Dose Cohorts and An Additional Single Ascending Dose Cohort
|
---|---|
Zeitschrift: | Legal Monitor Worldwide, 2021-05-19 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|